The relationship between cannabis and anorexia nervosa: a scoping review

Abstract Background Relapse rates in Anorexia Nervosa (AN) remain high, warranting exploration of further treatments. Cannabinoid agonists are of interest as they have shown successful outcomes in the treatment of associated conditions, such as post-traumatic stress disorder. This scoping review exp...

Full description

Bibliographic Details
Published in:	Journal of Eating Disorders
Main Authors:	Chloe I. Rogers, Carly R. Pacanowski
Format:	Article
Language:	English
Published:	BMC 2023-10-01
Subjects:	Cannabis Endocannabinoids Cannabinoid receptors Cannabis use disorder Cannabis harms Anorexia nervosa
Online Access:	https://doi.org/10.1186/s40337-023-00887-9

Similar Items

Case Report: Substance fixation in autism spectrum disorder with resultant anorexia nervosa
by: Lucas Arney, et al.
Published: (2025-09-01)

Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses
by: Zeinab Breijyeh, et al.
Published: (2021-02-01)

The Role of Medicinal Cannabis as an Emerging Therapy for Opioid Use Disorder
by: Kelvin Le, et al.
Published: (2024-04-01)

Cannabinoids from Cannabis sp.: mechanism of their activity and potential health benefits in human body
by: Grzegorz Dąbrowski, et al.
Published: (2017-08-01)

Cannabinoids from Cannabis sp.: mechanism of their activity and potential health benefits in human body
by: Grzegorz Dąbrowski, et al.
Published: (2017-08-01)

Medicinal Cannabis and the Intestinal Microbiome
by: Luis Vitetta, et al.
Published: (2024-12-01)

Influence of the Synthetic Cannabinoid Agonist on Normal and Inflamed Cartilage: An In Vitro Study
by: Jiangyinzi Shang, et al.
Published: (2023-10-01)

Associations between recreational cannabis legalization and cannabis use disorder treatment outcomes in California, 2010–2021
by: Brittany Bass, et al.
Published: (2025-08-01)

The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies
by: Wujood Khayat, et al.
Published: (2022-06-01)

Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
by: Laura Orsolini, et al.
Published: (2019-08-01)

Cannabis use in the UK: a quantitative comparison of individual differences in medical and recreational cannabis users
by: Beata Ciesluk, et al.
Published: (2024-01-01)

Corrigendum: Cannabis use in the UK: a quantitative comparison of individual differences in medical and recreational cannabis users
by: Beata Ciesluk, et al.
Published: (2024-02-01)

Cannabis: Drug of abuse and therapeutic agent, two sides of the same coin
by: Ana Canseco-Alba, et al.
Published: (2023-07-01)

Terpenoids, Cannabimimetic Ligands, beyond the <i>Cannabis</i> Plant
by: Elaine C. D. Gonçalves, et al.
Published: (2020-03-01)

Global experience with medical cannabis use: indications and safety profile (literature review)
by: S.P. Kaidash, et al.
Published: (2025-09-01)

The effect of cannabinoids on wound healing: A review
by: Aniruddha C. Parikh, et al.
Published: (2024-02-01)

Modulation of the Endocannabinoid System: Vulnerability Factor and New Treatment Target for Stimulant Addiction.
by: Stéphanie eOlière, et al.
Published: (2013-09-01)

Breve reseña sobre la farmacología de los cannabinoides
by: José Ramón Pascual Simón, et al.

Can Prescribed Cannabinoids Substitute Cannabis?
by: A. Batalla
Published: (2022-06-01)

<i>Cannabis Sativa</i> Revisited—Crosstalk between microRNA Expression, Inflammation, Oxidative Stress, and Endocannabinoid Response System in Critically Ill Patients with Sepsis
by: Anca Raluca Dinu, et al.
Published: (2020-01-01)

Editorial: Cannabis and cannabinoids in psychiatry
by: Pooja R. Sarkar, et al.
Published: (2025-05-01)

Medical cannabis in the management of musculoskeletal pain: a systematic review of clinical trials
by: Przemysław Płatek, et al.
Published: (2024-12-01)

Assessing the adaptive role of cannabidiol (CBD) in Cannabis sativa defense against cannabis aphids
by: Jacob MacWilliams, et al.
Published: (2023-10-01)

Chemistry, metabolism, and toxicology of cannabis: clinical implications.
by: Priyamvada Sharma, et al.
Published: (2012-12-01)

Cannabis Use and Abuse in Nepal: A Review of Studies
by: Dhana Ratna Shakya, et al.
Published: (2021-09-01)

“The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
by: Mona Khoury, et al.
Published: (2022-02-01)

Full-Spectrum Cannabidiol for Treating Chronic Temporomandibular Arthralgia: A Case Report
by: Jo?o Paulo Colesanti Tanganeli, et al.
Published: (2023-07-01)

<i>Cannabis sativa</i> as an Herbal Ingredient: Problems and Prospects
by: Ayodeji O. Oriola, et al.
Published: (2024-07-01)

Why a distinct medical stream is necessary to support patients using cannabis for medical purposes
by: Cecilia Costiniuk, et al.
Published: (2023-07-01)

A national study of clinical discussions about cannabis use among Veteran patients prescribed opioids
by: Tauheed Zaman, et al.
Published: (2024-03-01)

Global epidemiology of cannabis use disorders and its trend from 1990 to 2019: Benchmarking analysis of the global burden of disease study
by: Kinjal Shah, et al.
Published: (2024-01-01)

Síndrome de hiperémesis cannabinoide: una revisión
by: R.A. Jiménez-Castillo, et al.
Published: (2025-04-01)

A Comprehensive Review on the Techniques for Extraction of Bioactive Compounds from Medicinal Cannabis
by: Hebah Muhsien Sabiah AL Ubeed, et al.
Published: (2022-01-01)

The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products
by: Emilio Russo, et al.
Published: (2024-07-01)

Structure-Activity Relationship of Cannabis Derived Compounds for the Treatment of Neuronal Activity-Related Diseases
by: Cristina Prandi, et al.
Published: (2018-06-01)

Exploração farmacológica do sistema endocanabinoide: novas perspectivas para o tratamento de transtornos de ansiedade e depressão? Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?
by: Viviane M. Saito, et al.
Published: (2010-05-01)

Cannabis for COVID-19: can cannabinoids quell the cytokine storm?
by: Emmanuel Shan Onaivi, et al.
Published: (2020-09-01)

Topical Use of <i>Cannabis sativa</i> L. Biochemicals
by: Léonid Mnekin, et al.
Published: (2021-09-01)

A “Good” Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use
by: Davide Fortin, et al.
Published: (2022-03-01)

Density of cannabis outlets vs. cannabis use behaviors and prevalent cannabis use disorder: findings from a nationally-representative survey
by: Wit Wichaidit, et al.
Published: (2024-04-01)